Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Macrophages key to liver cells relaxin'

Jan. 29, 2021

GSK discontinues phase II trial of GSK-2831781 in ulcerative colitis

Jan. 22, 2021

Thetis completes pre-IND meeting for TP-317 for inflammatory bowel disease

Jan. 21, 2021

FDA clears IND application for TERN-501 to be developed as treatment for NASH

Jan. 20, 2021

IL-37 and IL-1R8 deficiencies contribute to the pathogenesis of necrotizing enterocolitis

Jan. 15, 2021

First patient enrolled in phase IIb VISTAS study of volixibat in adults with PSC

Jan. 15, 2021

Japanese phase III trial of AJM-300 in ulcerative colitis meets primary endpoint

Jan. 13, 2021

Positive topline data from ongoing phase II LiFT study of LPCN-1144

Jan. 13, 2021

Gannex reports phase I data on ASC-41 supporting progression for NASH

Jan. 12, 2021

Promising data presented from phase II study of rifamycin SV-MMX in IBS-D

Jan. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...